We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
-6.12%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.96B
AUM Growth
-$641M
(-11%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
23.33%
Holding
765
New
46
Increased
242
Reduced
270
Closed
98
Avg Time Held
1.5
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$33.6M |
| 2 |
Amazon
AMZN
|
+$32.3M |
| 3 |
CEB
CEB Inc.
CEB
|
+$27.7M |
| 4 |
Gilead Sciences
GILD
|
+$27.3M |
| 5 |
Merck
MRK
|
+$25.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$49.9M |
| 2 |
TWX
Time Warner Inc
TWX
|
+$30.5M |
| 3 |
Stericycle Inc
SRCL
|
+$29.3M |
| 4 |
Macquarie Infrastructure Holdings, LLC
MIC
|
+$25M |
| 5 |
Sunoco
SUN
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.16% |
| 2 | Financials | 16.84% |
| 3 | Consumer Discretionary | 14.26% |
| 4 | Technology | 13.32% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
MDW
601
DELISTED
MIDWAY GOLD CORP (CANADA)
MDW
| – | – |
-84,100
| Closed | -$1K | – |
|
602
DELISTED
AMERICAN EAGLE ENERGY CORP NEW COM STK (NV)
AMZG
| $0 | ﹤0.01% |
25,150
| – | – |
2013 Q4
7 quarters
|
|
603
DELISTED
PUBLIC STORAGE DEPOSITARY REPSTG PFD SER X (MD)
PSA.PRX
| – | – |
-11,000
| Closed | -$258K | – |
|
|
FUQI
604
DELISTED
FUQI INTERNATIONAL INC COM
FUQI
| $0 | ﹤0.01% |
10,000
| – | – |
2013 Q4
7 quarters
|
|
|
HWFG
605
DELISTED
HARRINGTON WEST FINL GROUP INC
HWFG
| $0 | ﹤0.01% |
48,554
| – | – |
2013 Q3
8 quarters
|
|
606
DELISTED
ANTHRACITE CAP INC
AHR
| – | – |
-12,500
| Closed | – | – |
|
|
TMA
607
DELISTED
THORNBURG MTG INC COM NEW (MD)
TMA
| $0 | ﹤0.01% |
66,000
-100
| -0.2% | – |
2013 Q2
9 quarters
|
|
|
VEDL
608
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| – | – |
-48,997
| Closed | -$529K | – |
|
|
TAT
609
DELISTED
TransAtlantic Petroleum LTD.
TAT
| – | – |
-30,000
| Closed | -$153K | – |
|
|
WWAV
610
DELISTED
The WhiteWave Foods Company
WWAV
| – | – |
-18,161
| Closed | -$888K | – |
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, Geneva Advisors held 765 positions worth $4.96B, down 11% from $5.6B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geneva Advisors withdrew a net $193M in Q3 2015, closing 98 positions and reducing 270 holdings. Its most notable exit was Potash Corp Of Saskatchewan, an estimated $21.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Geneva Advisors opened a new position in Alphabet (Google) Class A worth $15.8M.
- Geneva Advisors's largest Q3 2015 buy was Alphabet (Google) Class A: 496,420 shares worth $15.8M.
- Geneva Advisors added most to Manhattan Associates in Q3 2015, an estimated $33.6M increase.
- Geneva Advisors's biggest Q3 2015 reduction was Biogen, cutting an estimated $49.9M.
- Geneva Advisors fully exited Potash Corp Of Saskatchewan in Q3 2015, selling an estimated $21.6M.
- Geneva Advisors's ten largest holdings make up 23% of its $4.96B portfolio in Q3 2015.
- Geneva Advisors opened 46 new positions and closed 98 in Q3 2015.
- Geneva Advisors's portfolio value fell 11% quarter-over-quarter to $4.96B.
Based on Geneva Advisors's 13F filing for Q3 2015, filed 3 Nov 2015.